drugset / Trial / NCT02508935
Pharmacokinetics (PK) and Safety Study of XARTEMIS® XR in Postsurgical Adolescent Subjects With Moderate to Severe Acute Pain
NaSingle-groupOpen-labelTreatment
Summary
Phase 4, multicenter, open-label, multiple-dose study of the pharmacokinetics (PK) and safety of XARTEMIS XR in postsurgical adolescent subjects aged 12 to 17 years with moderate to severe acute pain. The study will assess the safety of administering multiple doses of XARTEMIS XR in this population.
Timeline
- Start
- 2015-11-20
- Primary completion
- 2017-04-26
- Completion
- 2017-04-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Acetaminophen | Small molecule | 325 mg | — |
| Subject | Oxycodone | Other / unclassified | 7.5 mg | — |
Indications
No indication recorded.